Vorschau! Die Detailseite für diese Publikation wurde nicht aktiviert!
Factors associated with first line chemotherapy use in patients with hormone receptor positive, HER2 negative metastatic breast cancer – data from the PRAEGNANT breast cancer registry
Abstract
http://www.praegnant.org/fileadmin/PRAEGNANT/downloads/SABCS_2017_Chemoprediction_in_metastatic_breast_cancer.pdf
Mehr zum Titel
| Titel | Factors associated with first line chemotherapy use in patients with hormone receptor positive, HER2 negative metastatic breast cancer – data from the PRAEGNANT breast cancer registry |
|---|---|
| Medien | Cancer Research |
| Band | 78 (4_Supplement) |
| Verfasser | Jens Huober, Peter A. Fasching, Florin-Andrei Taran, Prof. Dr. Bernhard Volz, Friedrich Overkamp, Hans-Christian Kolberg, al et, Tanja N. Fehm |
| Seiten | Abstract: P3-11-07 |
| Veröffentlichungsdatum | 15.02.2018 |
| Zitation | Huober, Jens; Fasching, Peter A.; Taran, Florin-Andrei; Volz, Bernhard; Overkamp, Friedrich; Kolberg, Hans-Christian; et, al; Fehm, Tanja N. (2018): Factors associated with first line chemotherapy use in patients with hormone receptor positive, HER2 negative metastatic breast cancer – data from the PRAEGNANT breast cancer registry. Cancer Research 78 (4_Supplement), Abstract: P3-11-07. |